BCL-X L regulates TNF-α-mediated cell death independently of NF-kB, FLIP and IAPs

Cell Research

Volumn 18, Issue 10, 2008, Pages 1020-1036

  Gozzelino, Raffaella ^a   Sole, Carme ^a   Llecha, Nuria ^b   Segura, Miguel F ^a   Moubarak, Rana S ^c   Iglesias Guimarais, Victoria ^c   Perez Garcia, M Jose ^a   Reix, Stephanie ^c,d   Zhang, Jisheng ^a   Badiola, Nahuai ^c,d   Sanchis, Daniel ^a   Rodriguez Alvarez, Jose ^c,d   Trullas, Ramon ^e   Yuste, Victor J ^c   Comella, Joan X ^a,c,d  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Apoptosis; Bcl xL; Neuron; NF ?B; PC12; TNF

Indexed keywords

INTRACISTERNAL A-PARTICLES;

ANTIINFECTIVE AGENT; CASP8 PROTEIN, RAT; CASPASE 3; CASPASE 8; CASPASE 9; DACTINOMYCIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL X; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRAIN; DRUG ANTAGONISM; GENETICS; METABOLISM; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; APOPTOSIS; BCL-X PROTEIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CELLS, CULTURED; DACTINOMYCIN; INHIBITOR OF APOPTOSIS PROTEINS; NF-KAPPA B; PC12 CELLS; PROTEIN SYNTHESIS INHIBITORS; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53349101678     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2008.76     Document Type: Article

References (50)

1. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J Comp Neurol 1993; 337:543-567.
2. Perry VH, Tsao JW, Fearn S, Brown MC. Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice. Eur J Neurosci 1995; 7:271-280.
3. Raivich G, Liu ZQ, Kloss CU, et al. Cytotoxic potential of proinflammatory cytokines: combined deletion of TNF receptors TNFR1 and TNFR2 prevents motoneuron cell death after facial axotomy in adult mouse. Exp Neurol 2002; 178:186-193.
4. Sriram K, Matheson JM, Benkovic SA, et al. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. Faseb J 2002; 16:1474-1476.
5. Sriram K, Matheson JM, Benkovic SA, et al. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. Faseb J 2006; 20:670-682.
6. Martin-Villalba A, Hahne M, Kleber S, et al. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ 2001 ; 8:679-686.
7. Demjen D, Klussmann S, Kleber S, et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med 2004; 10:389-395.
8. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10:45-65.
9. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114:181-190.
10. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996; 274:782-784.
11. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996; 274:787-789.
12. Wang CY, Mayo MW, Baldwin JrAS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996; 274:784-787.
13. Martin SJ, Lennon SV, Bonham AM, Cotter TG. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145:1859-1867.
14. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998; 17:931-939.
15. Fulda S, Meyer E, Debatin KM. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000; 60:3947-3956.
16. Chen C, Edelstein LC, Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 2000; 20:2687-2695.
17. Sawada M, Nakashima S, Banno Y, et al. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 2000; 19:3508-3520.
18. Deng Y, Lin Y, Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 2002; 16:33-45.
19. Clohessy JG, Zhuang J, de Boer J, Gil-Gomez G, Brady HJ. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem 2006; 281:5750-5759.
20. Mielke K, Herdegen T. Fatal shift of signal transduction is an integral part of neuronal differentiation: JNKs realize TNFalpha-mediated apoptosis in neuronlike, but not naive, PC 12 cells. Mol Cell Neurosci 2002; 20:211-224.
21. Sohn D, Totzke G, Essmann F, et al. The proteasome is required for rapid initiation of death receptor-induced apoptosis. Mol Cell Biol 2006; 26:1967-1978.
22. Furusu A, Nakayama K, Xu Q, Konta T, Kitamura M. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha. J Cell Physiol 2007; 210:703-710.
23. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335:440-442.
24. Rodriguez MS, Wright J, Thompson J, et al Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 1996; 12:2425-2435.
25. Kroemer G, Martinez C. Pharmacological inhibition of programmed lymphocyte death. Immunol Today 1994; 15:235-242.
26. Chang L, Kamata H, Solinas G, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006; 124:601-613.
27. Deng Y, Ren X, Yang L, Lin Y, Wu X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003; 115:61-70.
28. Petersen SL, Wang L, Yalcin-Chin A, et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007; 12:445-456.
29. Varfolomeev E, Blankenship JW, Wayson SM, et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007; 131:669-681.
30. Vince JE, Wong WW, Khan N, et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007; 131:682-693.
31. Wu H, Tschopp J, Lin SC. Smac mimetics and TNFalpha: a dangerous liaison? Cell 2007; 131:655-658.
32. Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998; 16:395-419.
33. Fernandez Y, Espana L, Manas S, Fabra A, Sierra A. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ 2000; 7:350-359.
34. Chelyshev YA, Raginov IS, Guseva DS, Masgutov RF. Survival and phenotypic characteristics of axotomized neurons in spinal ganglia. Neurosci Behav Physiol 2005; 35:457-460.
35. Motoyama N, Wang F, Roth KA, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995; 267:1506-1510.
36. Nakayama K, Nakayama K, Negishi I, et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 1993; 261:1584-1588.
37. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75:229-240.
38. Gonzalez-Garcia M, Garcia I, Ding L, et al. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 1995; 92:4304-4308.
39. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994; 120:301-311.
40. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998; 18:1009-1019.
41. Krajewski S, Krajewska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145:1323-1336.
42. Yuste VJ, Bayascas JR, Llecha N, et al. The absence of oligonucleosomal DNA fragmentation during apoptosis of IMR-5 neuroblastoma cells: disappearance of the caspase-activated DNase. J Biol Chem 2001; 276:22323-22331.
43. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93:11382-11388.
44. Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72:9873-9880.
45. Sole C, Dolcet X, Segura MF, et al. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling. J Cell Biol 2004; 167:479-492.
46. Cullen BR. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 1987; 152:684-704.
47. Segura MF, Sole C, Pascual M, et al. The long form of Fas apoptotic inhibitory molecule is expressed specifically in neurons and protects them against death receptor-triggered apoptosis. J Neurosa 2007; 27:11228-11241.
48. Boix J, Llecha N, Yuste VJ, Comella JX. Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 1997; 36:811-821.
49. Yuste VJ, Sanchez-Lopez I, Sole C, et al. The prevention of the staurosporine-induced apoptosis by Bcl-X(L), but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells. J Neurochem 2002; 80:126-139.
50. Yuste VJ, Sanchez-Lopez I, Sole C, et al. The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA. J Biol Chem 2005; 280:35670-35683.